{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:43:28Z","timestamp":1782996208140,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1136\/ard.2004.031393","type":"journal-article","created":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T01:13:37Z","timestamp":1108170817000},"page":"1326-1330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lamivudine is not effective in primary Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"64","author":[{"given":"B","family":"Gescuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Whitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T E","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"J C","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.031393_bib1","first-page":"743","article-title":"Variation of MHC class I and II antigen expression in relation to lymphocytic infiltrates and interferon-gamma positive cells","volume":"17","author":"Hedfors","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/art.1780290908","article-title":"Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjogren's syndrome","volume":"29","author":"Fox","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib3","first-page":"475","article-title":"Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjogren's syndrome","volume":"61","author":"Lindahl","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2004.031393_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.130.1.203","article-title":"Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies","volume":"130","author":"Adamson","year":"1983","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.031393_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ard.50.10.691","article-title":"T cell receptor expression in Sjogren's syndrome","volume":"50","author":"Zumla","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/sarh.2002.32557","article-title":"TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome","volume":"31","author":"Anaya","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib8","first-page":"900","article-title":"Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes","volume":"25","author":"Guggenbuhl","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.57.1.20","article-title":"Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study","volume":"57","author":"Hay","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib10","first-page":"45","article-title":"Immunogenetics of Sjogren's syndrome","volume":"149","author":"Kassan","year":"1998","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1136\/ard.2004.031393_bib11","first-page":"382","article-title":"Locus DR in primary Sjogren's syndrome","volume":"102","author":"Panchovska","year":"2001","journal-title":"Bratisl Lek Listy"},{"key":"10.1136\/ard.2004.031393_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(92)90103-I","article-title":"Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjogren's syndrome","volume":"92","author":"Sawada","year":"1992","journal-title":"Am J Med"},{"key":"10.1136\/ard.2004.031393_bib13","first-page":"17","article-title":"Immunopathology of Sjogren's syndrome","volume":"149","author":"Tapinos","year":"1998","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1136\/ard.2004.031393_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1568-9972(02)00121-0","article-title":"Pathogenesis of Sjogren's syndrome","volume":"2","author":"Yamamoto","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2004.031393_bib15","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.4049\/jimmunol.164.5.2823","article-title":"Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome","volume":"164","author":"Sasaki","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.031393_bib16","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1172\/JCI118629","article-title":"Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome","volume":"97","author":"Matsumoto","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2004.031393_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/rheumatology\/36.6.622","article-title":"T-cell receptor in Sjogren's syndrome","volume":"36","author":"Sumida","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archinte.1987.00370050094016","article-title":"Sicca complex and infection with human immunodeficiency virus","volume":"147","author":"Couderc","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2004.031393_bib19","doi-asserted-by":"crossref","unstructured":"Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, et al. T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome. Lancet. 1988;i :177.","DOI":"10.1016\/S0140-6736(88)92744-4"},{"key":"10.1136\/ard.2004.031393_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.51.6.769","article-title":"Primary Sjogren's syndrome with antibodies to HTLV-I: clinical and laboratory features","volume":"51","author":"Eguchi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","article-title":"Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome","volume":"344","author":"Terada","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.031393_bib22","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","article-title":"Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia","volume":"88","author":"Tamiya","year":"1996","journal-title":"Blood"},{"key":"10.1136\/ard.2004.031393_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.1780330603","article-title":"Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy)","volume":"33","author":"Talal","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/jcp.50.3.223","article-title":"Retrovirus in salivary glands from patients with Sjogren's syndrome","volume":"50","author":"Yamano","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1136\/ard.2004.031393_bib25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.1701273","article-title":"Detection of a human intracisternal A-type retroviral particle antigenically related to HIV","volume":"250","author":"Garry","year":"1990","journal-title":"Science"},{"key":"10.1136\/ard.2004.031393_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/art.1780361015","article-title":"Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjogren's syndrome","volume":"36","author":"Mariette","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/341072a0","article-title":"Exocrinopathy resembling Sjogren's syndrome in HTLV-1 tax transgenic mice","volume":"341","author":"Green","year":"1989","journal-title":"Nature"},{"key":"10.1136\/ard.2004.031393_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/rheumatology\/38.9.814","article-title":"Zidovudine in primary Sjogren's syndrome","volume":"38","author":"Steinfeld","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.031393_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.11199","article-title":"Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results","volume":"49","author":"Cummins","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib31","first-page":"318","article-title":"Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical features","volume":"17","author":"Atkinson","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib32","first-page":"555","article-title":"Methotrexate in primary Sjogren's syndrome","volume":"14","author":"Skopouli","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780290501","article-title":"Sjogren's syndrome. Proposed criteria for classification","volume":"29","author":"Fox","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.1780270205","article-title":"Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases","volume":"27","author":"Daniels","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","article-title":"The histopathology of Sjogren's syndrome in labial salivary gland biopsies","volume":"37","author":"Greenspan","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1136\/ard.2004.031393_bib36","first-page":"487","article-title":"The role of randomization in clinical studies: myths and beliefs","volume":"52","author":"Abel","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ard.2004.031393_bib37","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.031393_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.52.5.360","article-title":"Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial","volume":"52","author":"Kruize","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.58.4.253","article-title":"Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers","volume":"58","author":"Tishler","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1136\/ard.2004.031393_bib40","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/0961203396005001081","article-title":"Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective, open-label study","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"issue":"Suppl 1","key":"10.1136\/ard.2004.031393_bib41","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1177\/0961203396005001071","article-title":"Antimalarials in Sjogren's syndrome \u2013 the Greek experience","volume":"5","author":"Manoussakis","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.2004.031393_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(88)90365-8","article-title":"Treatment of primary Sjogren's syndrome with hydroxychloroquine","volume":"85","author":"Fox","year":"1988","journal-title":"Am J Med"},{"key":"10.1136\/ard.2004.031393_bib43","first-page":"246","article-title":"Cyclosporin a therapy in patients with primary Sjogren's syndrome: results at one year","volume":"61","author":"Drosos","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1136\/ard.2004.031393_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/ard.46.2.89","article-title":"Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjogren's syndrome","volume":"46","author":"Dalavanga","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2169\/internalmedicine.38.938","article-title":"Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjogren's syndrome","volume":"38","author":"Miyawaki","year":"1999","journal-title":"Intern Med"},{"key":"10.1136\/ard.2004.031393_bib46","first-page":"149","article-title":"Prednisone and piroxicam for treatment of primary Sjogren's syndrome","volume":"11","author":"Fox","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib47","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W","article-title":"Infliximab in patients with primary Sjogren's syndrome: a pilot study","volume":"44","author":"Steinfeld","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib48","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-857X(21)00055-7","article-title":"Criteria for diagnosis of Sjogren's syndrome","volume":"20","author":"Fox","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2004.031393_bib50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib51","unstructured":"Physician Desk Reference Online. Montvale, NJ: Thomas Healthcare, 2003\u20134."},{"key":"10.1136\/ard.2004.031393_bib52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/978-1-4615-5359-5_139","article-title":"Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjogrens syndrome","volume":"438","author":"Papas","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1136\/ard.2004.031393_bib53","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.031393_bib54","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","article-title":"Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial","volume":"162","author":"Fife","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2004.031393_bib55","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/rheumatology\/40.10.1085","article-title":"Outcome measures in Sjogren's syndrome","volume":"40","author":"Asmussen","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.031393_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/03009740232081788832","article-title":"Collaborative research into outcome measures in Sjogren's syndrome. Update on disease assessment","author":"Bowman","year":"2002","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1136\/ard.2004.031393_bib57","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/rheumatology\/40.10.1180","article-title":"Revisiting Sjogren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK","volume":"40","author":"Bowman","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.031393_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00003226-199801000-00007","article-title":"Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation","volume":"17","author":"Pflugfelder","year":"1998","journal-title":"Cornea"},{"key":"10.1136\/ard.2004.031393_bib59","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0161-6420(97)30125-0","article-title":"Relation between signs and symptoms of dry eye in the elderly. A population-based perspective","volume":"104","author":"Schein","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1136\/ard.2004.031393_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ageing\/27.1.63","article-title":"Validity and sensitivity of visual analogue scales in young and older healthy subjects","volume":"27","author":"Tiplady","year":"1998","journal-title":"Age Ageing"},{"key":"10.1136\/ard.2004.031393_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-3083.1999.00490.x","article-title":"An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression","volume":"49","author":"Humphreys-Beher","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.2004.031393_bib62","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/32.7.578","article-title":"Progression of sialadenitis in Sjogren's syndrome","volume":"32","author":"Jonsson","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.031393_bib63","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.51.6.777","article-title":"Follow up study of labial salivary gland lesions in primary Sjogren's syndrome","volume":"51","author":"Leroy","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031393_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1741-2358.2002.00053.x","article-title":"Health-related quality of life in patients with primary Sjogren's syndrome and xerostomia: a comparative study","volume":"19","author":"Rostron","year":"2002","journal-title":"Gerodontology"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724428574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724428574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.031393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:20:09Z","timestamp":1736140809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724428574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0003496724428574"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.031393","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lamivudine is not effective in primary Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.031393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}